Regenxbio RGNX
NASDAQ RGNX
$7.40 +0.25 (+3.50%)
At close: Oct 20, 2026 · 4:00 PM EDT

Regenxbio (RGNX) Other financing activities (2015 - 2025)

Updated

Regenxbio's Other financing activities came in at $196 million for FY2021, unchanged from $196 million in FY2020.

Analysis

Regenxbio (RGNX) Other financing activities (2015 - 2025) Analysis & Trends

  • Per Business Quant, earlier years put Other financing activities at $196 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Regenxbio 391.13 Mn -541.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -5.59 Mn
Dec 31, 2024 -7.61 Mn
Sep 30, 2024 -11.48 Mn
Jun 30, 2024 -9.53 Mn
Mar 31, 2024 -11.23 Mn
Dec 31, 2023 -11.75 Mn
Sep 30, 2023 -10.96 Mn
Jun 30, 2023 -9.91 Mn
Mar 31, 2023 -9.67 Mn
Dec 31, 2022 -8.96 Mn
Sep 30, 2022 -7.45 Mn
Jun 30, 2022 -9.18 Mn
Mar 31, 2022 -7.51 Mn
Dec 31, 2021 -8.60 Mn
Sep 30, 2021 -5.15 Mn
Jun 30, 2021 -6.41 Mn
Mar 31, 2021 -6.81 Mn
Dec 31, 2018 -157,000.00
Sep 30, 2017 -226,000.00
Jun 30, 2017 -135,000.00
API Access

Regenxbio Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=RGNX&period=max&api_key=YOUR_API_KEY